Holen Sie sich die Stockscreener-App
40.67
0.88%
-0.36
Handel nachbörslich:
40.67
Schlusskurs vom Vortag:
$41.03
Offen:
$40.85
24-Stunden-Volumen:
20,887
Relative Volume:
0.37
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.57%
1M Leistung:
+5.47%
6M Leistung:
-12.24%
1J Leistung:
-0.27%
1-Tages-Spanne:
$40.54
$40.88
1-Wochen-Bereich:
$39.90
$41.36
52-Wochen-Spanne:
$35.22
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
40.67 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
563.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.85 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
485.93 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - TradingView
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate
Russell Investments Group Ltd. Purchases 420 Shares of SPDR MSCI USA Gender Diversity Index ETF (NYSEARCA:SHE) - Defense World
Bank of Montreal Can Reduces Stock Position in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) - Defense World
Bank of Montreal Can Decreases Stock Position in SPDR NYSE Technology ETF (NYSEARCA:XNTK) - Defense World
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Wells Fargo & Company MN Increases Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Roche (RHHBY): Significant U.S. Investment to Enhance Manufacturing and Innovation - Value The Markets
Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges - TradingView
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot - Benzinga
UnitedHealth Woes Aren’t Dragging Down the Entire Sector. Here’s Why. - Barron's
Short bets against S&P 500 healthcare stocks rise in March; MRNA stays top shorted (XLV:NYSEARCA) - Seeking Alpha
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Top SA Quant-rated healthcare stocks as Q1 earnings unfold - Seeking Alpha
Tariffs threaten generic drug production and supplyFmr. FDA commissioner (XPH:NYSEARCA) - Seeking Alpha
Trump says pharma tariffs are coming soon (PPH:NASDAQ) - Seeking Alpha
National Bank of Canada FI Has $26,000 Holdings in SPDR Dow Jones International Real Estate ETF (NYSEARCA:RWX) - Defense World
Pharma, MedTech stocks bounce back as Trump pauses tariffs - MSN
Commonwealth Equity Services LLC Has $203,000 Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
A $576 Billion Stock-ETF Juggernaut Hit by Extreme Dislocations - Yahoo Finance
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Increases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Raymond James Financial Inc. Makes New Investment in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Commonwealth Equity Services LLC Has $489,000 Stock Position in SPDR S&P China ETF (NYSEARCA:GXC) - Defense World
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On? - Benzinga
10 Stocks of the S&P 500 ETF Up More Than 20% in Q1 - TradingView
WHO to shed jobs and slash budget by a fifth amid U.S. funding cuts: Reuters - Seeking Alpha
5 Best S&P 500 Index Funds to Buy Now - U.S News & World Report Money
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Tariff Uncertainty, Lowered FedEx Outlook - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell as Investors Digest Fed's Rate Decision - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Rate Decision - TradingView
Haleon (HLN): Pfizer Sells Stake in Consumer Healthcare Firm - Value the Markets
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Acquired by Jones Financial Companies Lllp - Defense World
US Bancorp DE Invests $96,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Reduced Government Shutdown Risk - TradingView
Select Sector SPDR ETFs: Strategic Investment with Sector-Specific Allocations - FinancialContent
Is the SPDR S&P 500 ETF Trust the Smartest Investment You Can Make Today? - Mitrade
Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations - Benzinga
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Stocks Drop As Trade War Escalates: What's Driving Markets Tuesday?SPDR S&P 500 (ARCA:SPY) - Benzinga
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027 - Benzinga
Sector Update: Health Care Stocks Steady Pre-Bell Friday - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Upcoming Economic Data - TradingView
Long Term Trading Analysis for (XPH) - Stock Traders Daily
Blue Trust Inc. Has $228,000 Holdings in SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
What Top-Performing Healthcare Funds Are Buying Now - Barron's
Ken Griffin's Citadel Places Big Short Bet Against GSKHere's What It Means for Investors - Benzinga India
Learn to Evaluate (XPH) using the Charts - Stock Traders Daily
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):